retatrutide 10mg vial Retatrutide 10mg Triple Agonist |
Description
Trulicity: A weekly injection approved for adults and children (10+) with type 2 diabetes, also carrying cardiovascular benefit language
The key differentiator mechanistically is GCGR activation: tirzepatide has no glucagon component
Ask for references from other patients and check online reviews before committing
Zepbound: Approved for chronic weight management in adults with obesity, or those who are overweight with at least one weight-related comorbidity (such as hypertension or dyslipidemia)
In the case of GLP-1s, patients are operating outside their insurance and even a drugs current indication to get the treatment they want
